Author Archives: theapoth

Low Dose Naltrexone (LDN): Harnessing Physiology to Fight Cancer, Fibromyalgia, MS, and Crohn’s Disease

Here’s the “boring” background:  Naltrexone HCl was approved by the FDA in 1984 for the treatment of opioid (“narcotic”) addiction. Naltrexone 50 mg. tablets block opioids from stimulating their receptors to prevent a “high” for addicts. Of course, if someone takes 50 mg. of naltrexone, it would also block opioids from achieving their legitimate purpose […]